MAIA Biotechnology, Inc. (MAIA) Dividend History

Company News

• MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga

  MAIA Biotechnology's lung cancer drug THIO, sequenced with Regeneron's cemiplimab, has shown promising long-term benefits in advanced non-small-cell-lung-cancer patients who failed previous treatments. The treatment has been well-tolerated with lower toxicity than standard-of-care, and some patients have continued the treatment for over 12 months, demonstrating safety, efficacy, and ongoing benefits.

  Benzinga

  Featured Companies: REGN
• MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor

  CHICAGO, IL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the appointment of immuno-oncology leader Remus Vezan, M.D., Ph.D., to its Scientific Advisory Board (SAB).

  GlobeNewswire Inc.
• MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer

  CHICAGO, IL, Feb. 22, 2024 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that enrollment is now complete in its Phase 2 THIO-101 go-to-market clinical trial evaluating THIO sequenced with the immune checkpoint inhibitor (CPI) cemiplimab (Libtayo®) in advanced non-small cell lung cancer (NSCLC).

  GlobeNewswire Inc.
• MAIA Soars 20% on Interim Results From Lung Cancer Study

  MAIA Biotechnology (MAIA) reports updated results from a mid-stage study. Patients treated with its lead drug achieved disease control rates that were well-sustained compared with previous scans.

  Zacks Investment Research

  Featured Companies: CTMX REGN
• Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session

  Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial results, issued guidance and declared an interim dividend. Wipro shares jumped 16.7% to $6.27 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Charge Enterprises, Inc. (NASDAQ: CRGE) shares surged 144.8% to $0.1988 after falling 9% on Thursday. Volcon, Inc. (NASDAQ: VLCN) shares climbed 47.3% to $0.1458 after gaining over 11% on Thursday. Mega Matrix Corp. (NYSE: MPU) rose 28.2% to $3.63. Applied UV, Inc. (NASDAQ: AUVI) gained 27% to $2.8896 after the company announced the launch of its Fighter Flex LED solution at the upcoming AHR Expo on January 22nd. Nuvve Holding Corp. (NASDAQ: NVVE) rose 25% to $0.1221 Akso Health Group (NASDAQ: AHG) surged 24.3% to $1.1069. Spectral AI, Inc. (NASDAQ: MDAI) shares rose 23.1% to $3.14. Spectral AI started enrollment in pivotal study to validate DeepView AI for burn injuries. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) jumped 23% to $0.4479. SMX secured a $5 million contract with R&I for NATO supply chain transparency. Flexsteel Industries, Inc. (NASDAQ: FLXS) gained 20.8% to $21.76 after the company reported strong preliminary results for the second quarter. The company said it sees preliminary earnings of 57 cents per share, versus analysts’ estimates of 27 cents per share. The company sees revenue of $100.1 million versus expectations of $96.77 million. Flexsteel Industries also issued financial guidance for the remainder of fiscal year 2024 and fiscal year 2025. Airspan Networks Holdings Inc. (NYSE:

  Benzinga

  Featured Companies: AAL AERT BTM CDE DAL EJH ESPR EVOK FLXS FTFT GNS GRPN IAG LAES MARA MDAI MNTS MPU NUKK NVVE RDZN RXT SMX UAL VCIG VLCN VVPR ZJYL